ABELCET is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Leadiant Biosciences, Inc.. The primary component is Amphotericin B; Dimyristoylphosphatidylcholine, Dl-; Dimyristoylphosphatidylglycerol, Dl-.
| Product ID | 57665-101_6ecda967-3197-42b0-8ee5-4541a78866a7 |
| NDC | 57665-101 |
| Product Type | Human Prescription Drug |
| Proprietary Name | ABELCET |
| Generic Name | Amphotericin B, Dimyristoylphosphatidylcholine, Dl- And Dimyristoylphosphatidylglycerol, Dl- |
| Dosage Form | Injection |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2010-10-18 |
| Marketing Category | NDA / NDA |
| Application Number | NDA050724 |
| Labeler Name | Leadiant Biosciences, Inc. |
| Substance Name | AMPHOTERICIN B; DIMYRISTOYLPHOSPHATIDYLCHOLINE, DL-; DIMYRISTOYLPHOSPHATIDYLGLYCEROL, DL- |
| Active Ingredient Strength | 5 mg/mL; mg/mL; mg/mL |
| Pharm Classes | Lipid-based Polyene Antifungal [EPC],Polyene Antifungal [EPC],Polyenes [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2010-10-18 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA050724 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2010-10-18 |
| Ingredient | Strength |
|---|---|
| AMPHOTERICIN B | 5 mg/mL |
| SPL SET ID: | 5587db37-f21a-4a39-a319-e1077032ced9 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() ABELCET 74600644 1974363 Live/Registered |
LEADIANT BIOSCIENCES LIMITED 1994-11-18 |